Keywords: UK, ABPI, Medical research, Pricing negotiations

UK pharma industry head fears for future of UK medical research

Article | 06 June 2012

The UK government is too focused on encouraging “breakthrough drugs” at the expense of significant gains for patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in